Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Sundararajan, S. Esampalli, A. Hakeem, C. Ramesh, S. Vinjamuri, M. J. Ledson, M. J. Walshaw (Liverpool, United Kingdom). Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients. Eur Respir J 2007; 30: Suppl. 51, 3894

Member's Comments

No comment yet.

Related content which might interest you: Agreement between tumor measurement on computer tomography and resected specimen size in lung cancer Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging Source: Eur Respir J 2007; 30: Suppl. 51, 430s Year: 2007 Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 The surveillance of recurred/refractory lung malignancy using whole-body MRI: Correlation with the results assessed by PET-CT Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 A lung cancer patient with multiple lesions on PET scan Source: Annual Congress 2006 - Clinical Grand Round: an interactive session Year: 2006 Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer> Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 Management of a large tumour Source: Annual Congress 2005 - Oncology Grand Round: an interactive session Year: 2005 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Incidental detection by computed tomography is an independent prognostic factor for survival in patients operated for nonsmall cell lung carcinoma Source: ERJ Open Res, 3 (2) 00106-2016; 10.1183/23120541.00106-2016 Year: 2017 A value of ultrasonographic predictors of malignancy in left adrenal gland in lung cancer patients – a comparison of EUS-b, CT and PET-CT Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 The clinical value of fluorescence bronchoscopy in predicting survivals in patients with small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 150s Year: 2006 Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005 Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 The value of lung perfusion scintigraphy in the prediction of postoperative function in lung cancer Source: Annual Congress 2004 - Assessment of lung function before resection of lung cancer Year: 2004